.

Searching for good investment opportunities can be both exciting and rewarding, especially when guided by the detailed observations of seasoned investors like Mukul Agrawal. 

Here, we will go through Mukul Agrawal’s portfolio in Q3 FY23-24, focusing on five stocks that have witnessed a large increase in interest from Foreign Institutional Investors (FIIs). 

Strides Pharma Science Ltd. 

As of December 2023, the ace investor bought fresh stakes in Strides Pharma Science Ltd. of 14 lakh equity shares, which is around 1.52 percent of the equity stake in the company with a holding value of Rs. 98.1 crore. 

The foreign investors in Strides Pharma increased by 2.2 percent from 17.25 percent in Q2 FY23-24 to 19.45 percent in Q3 FY23-24. 

With a market cap of Rs. 6,454 crore, the share price of Strides Pharma moved down by nearly 2.15 percent to close at Rs. 700.00 on Friday, compared to its previous closing price of Rs. 715.40 on NSE. 

The company has given over 60.0 percent returns in the last six months and nearly 134.55 percent in the last one year, whereas, so far in 2024, it delivered positive returns of around 7.0 percent. 

The company’s revenue from operations grew by around 4.0 percent from Rs. 999 crore in the Q2 FY23-24 to Rs. 1,038 crore in Q3 FY23-24, accompanied by an increase in the net profit by 136.24 percent to Rs. 54 crore in Q3 FY23-24 from a loss of Rs. 149 crore in Q2 FY23-24. 

A global pharmaceutical company, Strides Pharma Science Ltd. was incorporated in 1990 and has two business verticals, namely, regulated markets and emerging markets. The company is engaged in the business of development and manufacturing of pharmaceutical products. 

Neuland Laboratories Ltd. 

Established in 1984, Neuland is a leading manufacturer of active pharmaceutical ingredients (APIs) and provides solutions for the pharmaceutical industry’s chemistry needs. 

As of December 2023, Mukul Agrawal has stake of 4 lakh equity shares in the company, which is nearly 3.12 percent of the equity stake in Neuland Laboratories, with a holding value of Rs. 261.7 crore. 

With a market capitalisation of Rs. 8,705 crore, the FIIs holdings in the company increased by 1.12 percent from 21.57 percent in Q2 FY23-24 to 22.69 percent in Q3 FY23-24. 

The company’s share price increased by 4.01 percent on February 9th to close at Rs. 6,774.80, up by 4.01 percent, and hit a new all-time high at Rs. 6,910.0, whereas, its previous closing price was Rs. 6,513.30. 

It has delivered positive returns of over 69.1 percent in the last six months, whereas nearly 378.9 percent in the last one year. So far in 2024, it has given positive returns of around 28.42 percent. 

Radico Khaitan Ltd 

With a market cap of Rs. 23,017 crore, Mukul Agrawal has stakes of 14,00,083 equity shares or 1.05 percent of the stake in Brand Radico Khaitan Ltd. with a holding value of Rs. 244.6 crore. 

While the Promoters holdings remain unchanged at 40.26 percent, the FIIs have increased holdings by 0.83 percent from 18.18 percent in Q2 FY23-24 to 19.01 percent in Q3 FY23-24. 

The company’s revenue from operations grew by 25.51 percent QoQ to Rs. 1,161 crore in Q3 FY23-24 from Rs. 925 crore in Q2 FY23-24, accompanied by an increase in net profit by 15.38 percent on a QoQ basis from Rs. 65 crore to Rs. 75 crore in the same period. 

The share price of Radico Khaitan Ltd. moved down by 1.33 percent on February 9th and closed at Rs. 1,719.50 from its previous close of Rs. 1,742.65. The company has given over 26.0 percent returns in the past six months and nearly 51.2 percent in the last one year. So far, it has yielded returns of around 1.98 percent in 2024. 

Radico Khaitan Ltd. (RKL), formerly known as Rampur Distillery, is one of the oldest and the largest manufacturers of Indian Made Foreign Liquor (IMFL) brands in India. 

Intellect Design Arena Ltd 

The ace investor has 23 lakh equity shares, which is around 1.68 percent of the equity stake in Intellect Design Arena with a holding value of Rs. 230 crore. 

The company’s share price fell by 5.02 percent on February 9th and closed at Rs. 996.30 crore, whereas, its previous closing price was Rs. 1,048.95. On February 8th, the stock hit a new 52-week high at Rs. 1,058. 

With a market cap of Rs. 13,672 crore, the foreign investors in the company increased by 0.7 percent from 24.39 percent in Q2 FY23-24 to 25.09 percent in Q3 FY23-24. 

It has given over 44.8 percent returns in the last six months and nearly 114.5 percent in the last one year, whereas, so far in 2024, the returns delivered positive returns of more than 20.1 percent. 

Incorporated in 2011, Intellect Design Arena Limited is a global leader in financial technology for banking, insurance and other financial services. 

PDS Ltd. 

PDS Ltd. is a global consumer-driven manufacturing and sourcing platform and is engaged in the trading of garments, investment holding, design, development, marketing, sourcing and distribution of readymade garments of all kinds and other consumer products globally. 

The ace investor, Mukul Agrawal, has stakes of 34.82 lakh equity shares in the company, which is nearly 2.64 percent of the equity stake in PDS Ltd., with a holding value of Rs. 187.5 crore. 

With a market capitalisation of Rs. 7,109 crore, the FIIs holdings in the company increased by 0.45 percent from 2.97 percent in Q2 FY23-24 to 3.42 percent in Q3 FY23-24. 

The company’s share price increased by 1.12 percent on February 9th to close at Rs. 539.35, whereas, its previous closing price was Rs. 533.40. It has delivered positive returns of over 66.5 percent in the last six months, whereas nearly 71.32 percent in the last one year. So far in 2024, it has given positive returns of around 2.17 percent.

Written by Shivani Singh

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.